In conclusion, these findings identify a Sox2–Sox9 network as crucial for stem/progenitor cell maintenance in the human mammary gland and warrant further research into the potential of Sox family transcription factors as therapeutic targets in certain types of breast cancer. Here, SOX9 is linked to breast carcinoma.